Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results

Hansa Biopharma Hosts Virtual Event with Transplant Surgeons

Hansa Biopharma AB announced a virtual event featuring Professor Robert Montgomery and Professor Matthew Cooper to discuss the medical journey of highly sensitized patients awaiting a kidney transplant.

The event will take place on November 12, 2025, at 9:00 AM EST / 15:00 PM CET, and will provide insights into clinical practice and imlifidase Phase 3 results.

The event features two distinguished transplant surgeons to share perspectives on the clinical relevance of the topline results from the US Phase 3 ConfIdeS study.

For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.

Author summary: Hansa Biopharma hosts a virtual event on kidney transplant.

more

PR Newswire UK PR Newswire UK — 2025-10-29

More News